Search

Artificial intelligence is rapidly reshaping the landscape of health care, revolutionizing scientific discovery, drug development, diagnosis and treatment, as well as health care delivery operations. As with any emerging technology, its success lies in its implementation, and The University of Texas

The risk of dying while waiting for a liver transplant or having a transplant fail for patients with alcohol-associated liver diseases is higher among racial and ethnic minorities, according to UT Southwestern Medical Center researchers.

A molecule has demonstrated its ability to kill tumor cells and incite an immune response in preclinical models of small cell lung cancer (SCLC), according to UT Southwestern Medical Center researchers.

Automated external defibrillators (AEDs) are underutilized during cardiac arrest episodes despite laws in some states requiring their availability in high-risk areas such as athletic facilities, researchers at UT Southwestern Medical Center found. The devices can save lives by shocking the heart

A nanoparticle-based therapy developed by UT Southwestern Medical Center scientists stimulated an immune pathway that eradicated tumors in mouse models of various cancer types.

A gene called Npas4, already known to play a key role in balancing excitatory and inhibitory inputs in brain cells, appears to also be a master timekeeper for the brain’s circadian clock, new research led by UT Southwestern scientists suggests.

Two postdoctoral researchers at UT Southwestern Medical Center are among 25 early-career scientists nationwide selected as Howard Hughes Medical Institute (HHMI) Hanna H. Gray Fellows for 2023.

A majority of Americans suffering from heart failure face substantial socioeconomic challenges, researchers at UT Southwestern Medical Center found.A majority of Americans suffering from heart failure face substantial socioeconomic challenges, researchers at UT Southwestern Medical Center found. The

Researchers at UT Southwestern Medical Center have discovered an intracellular mechanism that converts protective intestinal cells into disease-driving pathogenic cells, a finding that could lead to improved treatments for patients with inflammatory bowel disease (IBD).

Although hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are eligible for high-intensity statin therapy, most are not using the drugs, UT Southwestern Medical Center researchers report.